News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
2,580 Results
Type
Article (332)
Company Profile (1)
Press Release (2247)
Section
Business (818)
Career Advice (4)
Deals (150)
Drug Development (615)
FDA (67)
Job Trends (59)
News (1519)
Policy (146)
Tag
Academia (9)
Allergies (1)
Alliances (165)
Antibody-drug conjugate (ADC) (6)
Approvals (78)
Artificial intelligence (2)
Autoimmune disease (2)
Best Places to Work (52)
Breast cancer (3)
Cancer (70)
Career advice (4)
Cell therapy (3)
Clinical research (579)
Collaboration (13)
Compensation (13)
COVID-19 (35)
C-suite (6)
Data (63)
Diabetes (8)
Diagnostics (14)
Drug pricing (1)
Earnings (430)
Events (470)
Executive appointments (10)
FDA (97)
Funding (1)
GLP-1 (15)
Government (25)
Guidances (5)
Healthcare (48)
Immunology and inflammation (3)
Immuno-oncology (2)
Indications (1)
Infectious disease (36)
Inflammatory bowel disease (1)
Influenza (1)
Interviews (1)
IPO (81)
Job creations (10)
Job search strategy (4)
JPM (1)
Layoffs (5)
Legal (10)
Liver cancer (2)
Lung cancer (12)
Lymphoma (11)
Manufacturing (3)
MASH (1)
Medical device (5)
Medtech (5)
Mergers & acquisitions (69)
Metabolic disorders (13)
Neuroscience (1)
NextGen: Class of 2026 (14)
Non-profit (9)
Obesity (3)
Opinion (4)
Ovarian cancer (4)
Pancreatic cancer (5)
Patient recruitment (2)
People (251)
Pharmaceutical (1)
Phase 1 (190)
Phase 2 (261)
Phase 3 (270)
Pipeline (44)
Policy (1)
Postmarket research (5)
Preclinical (22)
Rare diseases (3)
Real estate (14)
Regulatory (170)
Research institute (4)
Schizophrenia (1)
Sickle cell disease (1)
Startups (8)
Vaccines (14)
Weight loss (3)
Date
Last 7 days (3)
Last 30 days (9)
Last 365 days (201)
2026 (11)
2025 (211)
2024 (179)
2023 (172)
2022 (235)
2021 (277)
2020 (290)
2019 (209)
2018 (154)
2017 (199)
2016 (141)
2015 (103)
2014 (76)
2013 (44)
2012 (53)
2011 (42)
2010 (41)
Location
Africa (3)
Asia (474)
Australia (8)
California (99)
Canada (7)
China (70)
Delaware (92)
Europe (276)
Florida (1)
Illinois (3)
Indiana (7)
Japan (2)
Maryland (7)
Massachusetts (28)
Nevada (1)
New Jersey (3)
New York (16)
North Carolina (1)
Northern California (85)
Ohio (2)
Pennsylvania (5)
South America (3)
Southern California (7)
Texas (5)
United States (259)
2,580 Results for "incyte corporation.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
January 28, 2026
·
1 min read
Press Releases
Incyte Announces Change to its Board of Directors
December 15, 2025
·
1 min read
Press Releases
Incyte to Present at Upcoming Investor Conference - December 18, 2025
December 19, 2025
·
1 min read
Press Releases
Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
December 8, 2025
·
6 min read
Press Releases
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
November 7, 2025
·
13 min read
Press Releases
Incyte to Present at Upcoming December 2025 Investor Conferences
November 20, 2025
·
1 min read
Press Releases
Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel
December 2, 2025
·
3 min read
Press Releases
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
February 1, 2026
·
8 min read
Press Releases
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer
December 23, 2025
·
7 min read
Press Releases
Incyte to Present at Upcoming November 2025 Investor Conferences
October 31, 2025
·
1 min read
1 of 258
Next
